Rapid estimation of hospital charges in patients with leukemia. Validation of a multivariate prediction model.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Medical Care

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005650-198909000-00005PMID 2770371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.

  1987cited by this paper
• Rapid Estimation of Hospitalization Charges From a Brief Medical Record Review: Evaluation of a Multivariate Prediction Model

  1986cited by this paper
• Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison.

  1984cited by this paper
• The distinction between cost and charges.

  1982cited by this paper
• Hospital cost per case: analyses using a statewide data system.

  1979cited by this paper

• Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.

  2006cites this paper
• Using Average Cost Methods to Estimate Encounter-Level Costs for Medical-Surgical Stays in the VA

  2003cites this paper
• Determination of VA Health Care Costs

  2003cites this paper
• Intermediate Short-Term Outcomes after Brain Computed Tomography and Magnetic Resonance Imaging in Neurology Outpatients

  2001cites this paper
• Predicting C osts o f S tem-Cell T ransplantation

  2000cites this paper
• Predicting costs of stem-cell transplantation.

  2000cites this paper
• Review of methods to determine VA health care costs.

  1999cites this paper
• Rapid MR imaging versus plain radiography in patients with low back pain: initial results of a randomized study.

  1997cites this paper
• Costing Methods in the Canadian Literature on the Economic Evaluation of Health Care: A Survey and Assessment

  1996cites this paper
• The clinical-economic trial: promise, problems, and challenges.

  1995cites this paper
• Effects of Recombinant Human DNase Therapy on Healthcare use and Costs in Patients with Cystic Fibrosis

  1995cites this paper
• Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.

  1994cites this paper
• Heroic measures when treating patients with hematologic malignancies - the economic cost of survival.

  1993cites this paper
• Treating acute leukaemias--a venture into economic uncertainty? A method for estimating the cost of treating patients with acute myelocytic leukaemia.

  1993cites this paper
• Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease

  1993cites this paper
• Marrow transplantation, cost effectiveness analysis and setting limits.

  1993cites this paper
• [A program for medical use of information systems. Validity of calculation of direct costs for the initial treatment of acute myeloblastic leukemia].

  1992cites this paper
• Fixed price contracts: the case of pediatric acute lymphoblastic leukemia.

  1992cites this paper
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease

  1992influential citation
• Cost of complete remission induction in acute myeloblastic leukemia: evaluation of the cost-effectiveness of a new drug.

  1992cites this paper
• Telephone care as a substitute for routine clinic follow-up.

  1992cites this paper